Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI for Cancer Detection Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Breast Cancer
1.2.3 Lung Cancer
1.2.4 Prostatic Cancer
1.2.5 Others
1.3 Market by Application
1.3.1 Global AI for Cancer Detection Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI for Cancer Detection Market Perspective (2018-2029)
2.2 AI for Cancer Detection Growth Trends by Region
2.2.1 Global AI for Cancer Detection Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 AI for Cancer Detection Historic Market Size by Region (2018-2023)
2.2.3 AI for Cancer Detection Forecasted Market Size by Region (2024-2029)
2.3 AI for Cancer Detection Market Dynamics
2.3.1 AI for Cancer Detection Industry Trends
2.3.2 AI for Cancer Detection Market Drivers
2.3.3 AI for Cancer Detection Market Challenges
2.3.4 AI for Cancer Detection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI for Cancer Detection Players by Revenue
3.1.1 Global Top AI for Cancer Detection Players by Revenue (2018-2023)
3.1.2 Global AI for Cancer Detection Revenue Market Share by Players (2018-2023)
3.2 Global AI for Cancer Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by AI for Cancer Detection Revenue
3.4 Global AI for Cancer Detection Market Concentration Ratio
3.4.1 Global AI for Cancer Detection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI for Cancer Detection Revenue in 2022
3.5 AI for Cancer Detection Key Players Head office and Area Served
3.6 Key Players AI for Cancer Detection Product Solution and Service
3.7 Date of Enter into AI for Cancer Detection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 AI for Cancer Detection Breakdown Data by Type
4.1 Global AI for Cancer Detection Historic Market Size by Type (2018-2023)
4.2 Global AI for Cancer Detection Forecasted Market Size by Type (2024-2029)
5 AI for Cancer Detection Breakdown Data by Application
5.1 Global AI for Cancer Detection Historic Market Size by Application (2018-2023)
5.2 Global AI for Cancer Detection Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America AI for Cancer Detection Market Size (2018-2029)
6.2 North America AI for Cancer Detection Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America AI for Cancer Detection Market Size by Country (2018-2023)
6.4 North America AI for Cancer Detection Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI for Cancer Detection Market Size (2018-2029)
7.2 Europe AI for Cancer Detection Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe AI for Cancer Detection Market Size by Country (2018-2023)
7.4 Europe AI for Cancer Detection Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI for Cancer Detection Market Size (2018-2029)
8.2 Asia-Pacific AI for Cancer Detection Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific AI for Cancer Detection Market Size by Region (2018-2023)
8.4 Asia-Pacific AI for Cancer Detection Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI for Cancer Detection Market Size (2018-2029)
9.2 Latin America AI for Cancer Detection Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America AI for Cancer Detection Market Size by Country (2018-2023)
9.4 Latin America AI for Cancer Detection Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI for Cancer Detection Market Size (2018-2029)
10.2 Middle East & Africa AI for Cancer Detection Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa AI for Cancer Detection Market Size by Country (2018-2023)
10.4 Middle East & Africa AI for Cancer Detection Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lunit Inc
11.1.1 Lunit Inc Company Detail
11.1.2 Lunit Inc Business Overview
11.1.3 Lunit Inc AI for Cancer Detection Introduction
11.1.4 Lunit Inc Revenue in AI for Cancer Detection Business (2018-2023)
11.1.5 Lunit Inc Recent Development
11.2 Xilis
11.2.1 Xilis Company Detail
11.2.2 Xilis Business Overview
11.2.3 Xilis AI for Cancer Detection Introduction
11.2.4 Xilis Revenue in AI for Cancer Detection Business (2018-2023)
11.2.5 Xilis Recent Development
11.3 Shukun Technology
11.3.1 Shukun Technology Company Detail
11.3.2 Shukun Technology Business Overview
11.3.3 Shukun Technology AI for Cancer Detection Introduction
11.3.4 Shukun Technology Revenue in AI for Cancer Detection Business (2018-2023)
11.3.5 Shukun Technology Recent Development
11.4 Kheiron
11.4.1 Kheiron Company Detail
11.4.2 Kheiron Business Overview
11.4.3 Kheiron AI for Cancer Detection Introduction
11.4.4 Kheiron Revenue in AI for Cancer Detection Business (2018-2023)
11.4.5 Kheiron Recent Development
11.5 SkinVision
11.5.1 SkinVision Company Detail
11.5.2 SkinVision Business Overview
11.5.3 SkinVision AI for Cancer Detection Introduction
11.5.4 SkinVision Revenue in AI for Cancer Detection Business (2018-2023)
11.5.5 SkinVision Recent Development
11.6 Infervision
11.6.1 Infervision Company Detail
11.6.2 Infervision Business Overview
11.6.3 Infervision AI for Cancer Detection Introduction
11.6.4 Infervision Revenue in AI for Cancer Detection Business (2018-2023)
11.6.5 Infervision Recent Development
11.7 Imagene AI
11.7.1 Imagene AI Company Detail
11.7.2 Imagene AI Business Overview
11.7.3 Imagene AI AI for Cancer Detection Introduction
11.7.4 Imagene AI Revenue in AI for Cancer Detection Business (2018-2023)
11.7.5 Imagene AI Recent Development
11.8 Oncora Medical
11.8.1 Oncora Medical Company Detail
11.8.2 Oncora Medical Business Overview
11.8.3 Oncora Medical AI for Cancer Detection Introduction
11.8.4 Oncora Medical Revenue in AI for Cancer Detection Business (2018-2023)
11.8.5 Oncora Medical Recent Development
11.9 Niramai Health Analytix
11.9.1 Niramai Health Analytix Company Detail
11.9.2 Niramai Health Analytix Business Overview
11.9.3 Niramai Health Analytix AI for Cancer Detection Introduction
11.9.4 Niramai Health Analytix Revenue in AI for Cancer Detection Business (2018-2023)
11.9.5 Niramai Health Analytix Recent Development
11.10 Enlitic
11.10.1 Enlitic Company Detail
11.10.2 Enlitic Business Overview
11.10.3 Enlitic AI for Cancer Detection Introduction
11.10.4 Enlitic Revenue in AI for Cancer Detection Business (2018-2023)
11.10.5 Enlitic Recent Development
11.11 Maxwell Plus
11.11.1 Maxwell Plus Company Detail
11.11.2 Maxwell Plus Business Overview
11.11.3 Maxwell Plus AI for Cancer Detection Introduction
11.11.4 Maxwell Plus Revenue in AI for Cancer Detection Business (2018-2023)
11.11.5 Maxwell Plus Recent Development
11.12 Therapixel
11.12.1 Therapixel Company Detail
11.12.2 Therapixel Business Overview
11.12.3 Therapixel AI for Cancer Detection Introduction
11.12.4 Therapixel Revenue in AI for Cancer Detection Business (2018-2023)
11.12.5 Therapixel Recent Development
11.13 Ibex
11.13.1 Ibex Company Detail
11.13.2 Ibex Business Overview
11.13.3 Ibex AI for Cancer Detection Introduction
11.13.4 Ibex Revenue in AI for Cancer Detection Business (2018-2023)
11.13.5 Ibex Recent Development
11.14 OrigiMed
11.14.1 OrigiMed Company Detail
11.14.2 OrigiMed Business Overview
11.14.3 OrigiMed AI for Cancer Detection Introduction
11.14.4 OrigiMed Revenue in AI for Cancer Detection Business (2018-2023)
11.14.5 OrigiMed Recent Development
11.15 Tencent
11.15.1 Tencent Company Detail
11.15.2 Tencent Business Overview
11.15.3 Tencent AI for Cancer Detection Introduction
11.15.4 Tencent Revenue in AI for Cancer Detection Business (2018-2023)
11.15.5 Tencent Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details